We, at OmniActive, invest over 10 per cent of the total outlay into R&D
Sanjaya Mariwala, Executive Chairman and MD, OmniActive Health Technologies shares insights into the company’s significant…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Department of Scientific and Industrial Research
DSIR renews recognition for Venus Remedies’ R&D unit
The company invested 3.53 per cent of its total sales in R&D, from which it has generated 5.25 per cent of its total revenue,…